Company Overview of Paragon Pharmaceuticals, LLC
Paragon Pharmaceuticals is a private equity and venture capital firm specializing in investing in startups and growth opportunities. It specializes in acquisition of pharmaceutical companies. The firm typically invests in licensing and developing drugs and other medical products and treatments, medical treatments and technologies, innovative life sciences, rare diseases, gastrointestinal illness, cancer, intense pain, oncology, central nervous system disorders, and drug development. It seeks to invest along with other investors and to acquire, in-license and distribute proprietary products. Paragon Pharmaceuticals was founded in December 2009 and is based in Northbrook, Illinois.
1033 Skokie Boulevard
Northbrook, IL 60062
Founded in 2009
Key Executives for Paragon Pharmaceuticals, LLC
Similar Private Companies By Industry
|@Visory LLC||United States|
|1 Road Partners LLC||United States|
|11T Partners, LLC||United States|
|123Jump.com, Inc.||United States|
|1509225 Ontario, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Paragon Pharmaceuticals, LLC, please visit www.paragonpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.